Terumo BCT, Inc. Sustainability Profile
Terumo BCT, Inc., a subsidiary of Terumo Corporation, is a leading player in the global medical technology industry, headquartered in the United States. Founded in 1964, the company has established itself as a pioneer in blood component and cellular therapies, with a strong presence in North America, Europe, and Asia. Specialising in innovative blood collection, processing, and transfusion solutions, Terumo BCT offers unique products such as the Trima Accel system and the Spectra Optia Apheresis System. These technologies enhance patient care by improving the efficiency and safety of blood management practices. With a commitment to advancing healthcare, Terumo BCT has achieved significant milestones, including numerous patents and recognitions for its contributions to the field. The company’s dedication to quality and innovation solidifies its position as a trusted partner in the healthcare community.
DitchCarbon Score
How does Terumo BCT, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Terumo BCT, Inc.'s score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Terumo BCT, Inc.'s reported carbon emissions
Terumo BCT, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Terumo Corporation, which cascades its climate commitments and emissions data. As part of its parent company's initiatives, Terumo BCT is aligned with the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), although specific reduction targets have not been detailed. While no absolute emissions figures are provided, Terumo Corporation's overarching climate strategy may influence Terumo BCT's commitments to reducing its carbon footprint. The company is expected to adhere to industry-standard climate terminology and practices, focusing on sustainability and emissions reduction in line with its parent organisation's goals. As of now, Terumo BCT has not publicly outlined specific reduction initiatives or achievements, indicating a potential area for future development in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2023 | |
|---|---|---|
| Scope 1 | 6,185,000 | 0,000,000 |
| Scope 2 | 25,654,000 | 00,000,000 |
| Scope 3 | 148,913,000 | 000,000,000 |
How Carbon Intensive is Terumo BCT, Inc.'s Industry?
How Carbon Intensive is Terumo BCT, Inc.'s Location?
Terumo BCT, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Terumo BCT, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
